| DC22956 |
VU0405601 |
A potent Kv11.1 (hERG) channel allosteric modulator that protects cardiac tissue from hERG-related drug-induced arrhythmias. |
|
| DC23571 |
NS5806
Featured
|
NS5806 is a potent potassium current activator, increases KV4.3/KChIP2 peak current amplitudes with an EC50 of 5.3 μM. NS5806 slows KV4.3 and KV4.2 current dacay in channel complexes containing KChIP2[1]. |
|
| DC23029 |
U 74389G maleate |
A potent lipid peroxidation inhibitor that has antishock and endothelial protective actions. |
|
| DC23951 |
Cevimeline hydrochloride
Featured
|
Cevimeline HCl is a cholinergic agonist that binds to muscarinic receptors. Muscarinic agonists in sufficient dosage can increase secretion of exocrine glands, such as salivary and sweat glands, and increase tone of the smooth muscle in the GI and urinary tracts. |
|
| DC23950 |
Cevimeline
Featured
|
Cevimeline is a parasympathomimetic and muscarinic agonist that affects M1 and M3 receptors. It is used in the treatment of dry mouth and Sjögren's syndrome. Cevimeline has also been shown to reduce Xerostomia symptoms and increase salivary flow in head and neck cancer survivors after radiotherapy. |
|
| DC20484 |
Otaplimastat |
A potent matrix metalloproteinase (MMP) inhibitor.. |
|
| DC11834 |
AM-6761 |
A potent MDM2-p53 interaction inhibitor with remarkable biochemical (HTRF IC50=0.1 nM), cellular potency (SJSA-1 EdU IC50=16 nM), and favorable pharmacokinetic properties. |
|
| DC11836 |
AM-8735 |
A potent MDM2-p53 interaction inhibitor with remarkable biochemical (HTRF IC50=0.4 nM), cellular potency (SJSA-1 EdU IC50=25 nM), and favorable pharmacokinetic properties. |
|
| DC22894 |
SHU-9119
Featured
|
A potent melanocortin MC3 and MC4 receptor antagonist with IC50 of 0.23 nM and 0.06 nM, respectively. |
|
| DC21341 |
MPT0B098 |
A potent microtubule inhibitor that not only inhibits the expression levels of HIF-1α protein but also destabilizes HIF-1α mRNA. |
|
| DC11883 |
Adarigiline |
A potent monoamine oxidase B (MAO-B) inhibitor.. |
|
| DC24045 |
T338C Src-IN-2 |
A potent mutant c-Src T338C kinase inhibitor with IC50 of 317 nM. |
|
| DC24044 |
T338C Src-IN-1 |
A potent mutant Src T338C inhibitor with IC50 of 111 nM. |
|
| DC21776 |
Candoxatrilat |
A potent neutral endopeptidase EC 3.4.24.11 (atriopeptidase) inhibitor that increases endogenous ANF levels and produces natriuretic and diuretic responses intravenously in mice.. |
|
| DC11771 |
AZ-27 |
A potent non-nucleoside RSV L-protein polymerase inhibitor with EC50 of 0.01 uM and 1.3 uM for RSV A2 and RSV B-WST, respectively. |
|
| DC11773 |
BI Compound D |
A potent non-nucleoside RSV L-protein polymerase inhibitor with IC50 of 89 nM. |
|
| DC22714 |
GR-159897 |
A potent non-peptide antagonist of tachykinin NK2 receptor with pKi of 9.5 in CHO cells. |
|
| DC24033 |
CDDO-EA
Featured
|
A potent Nrf2 activator that upregulates Nrf2 expression and resulted in translocation of Nrf2 into the nucleus.. |
|
| DC11786 |
THPN
Featured
|
A potent nuclear receptor TR3 (Nur77)-specific targeting compound that can induce melanoma autophagy through a mitochondrial signaling pathway. |
|
| DCAPI1443 |
Lamivudine |
A potent nucleoside analog reverse transcriptase inhibitor (nRTI). An analog of cytidine that can inhibit both types (1 and 2) of HIV reverse transcriptase as well as the reverse transcriptase of hepatitis B. Needs to be phosphorylated to its triphosphate |
|
| DC22591 |
BMS-690514 |
A potent pan HER/VEGFR inhibitor with IC50 of 5/20/60/50 nM for EGFR/HER2/ERBB4/VEGFR2 respectively. |
|
| DC21112 |
AR-42 |
A potent pan-HDAC inhibitor with IC50 of 16-30 nM, inhibits cell proliferation of P815, C2, and BR cells with IC50 of 0.65, 0.30, and 0.23 uM, respectively. |
|
| DC22925 |
BMS-1001 hydrochloride
Featured
|
A potent PD-1/PD-L1 interaction inhibitor with IC50 of 2.25 nM in a homogenous time-resolved fluorescence binding assay.. |
|
| DC22928 |
BMS-1001
Featured
|
A potent PD-1/PD-L1 interaction inhibitor with IC50 of 2.25 nM in a homogenous time-resolved fluorescence binding assay.. |
|
| DC22936 |
BMS-242 |
A potent PD-1/PD-L1 interaction inhibitor with IC50 of 6-100 nM in a homogenous time-resolved fluorescence binding assay.. |
|
| DC22935 |
BMS-200 |
A potent PD-1/PD-L1 interaction inhibitor with IC50 of 80 nM in a homogenous time-resolved fluorescence binding assay.. |
|
| DC22510 |
AN-3199 |
A potent PDE4 inhibitor with IC50 of 94.5 nM.. |
|
| DC22850 |
Genz 669178 |
A potent PfDHODH inhibitor that exhibits low nanomolar in vitro potency against DHODH from P falciparum, P vivax, and P berghei. |
|
| DC22976 |
PDE12-IN-3 |
A potent phosphodiesterase 12 (PDE12) with Ki of 17.5 nM, with no activity for related enzyme CNOT6 (Ki>10 uM). |
|
| DC22588 |
PK-14105 |
A potent photoaffinity ligand for the peripheral-type benzodiazepine binding site with Ki of 4 nM. |
|
